Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-9 of  9 results for ""glp-1""

Your Filters

Collection : Akademicka Platforma Czasopism (Apcz) Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of the effectiveness and safety of anti-obesity drugs - an update on the current state of knowledge on available and investigational drugs

Subjects: Obesity; anti-obesity drugs; GLP-1 analogs

  • Source: Journal of Education, Health and Sport; Tom 35 Nr 1 (2023); 94-112 ; Journal of Education, Health and Sport; Vol. 35 No. 1 (2023); 94-112 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

The Modern methods of obesity treatment - review of the literature

Subjects: GLP-1; obesity; obesity treatmen

  • Source: Quality in Sport; Tom 13 Nr 1 (2023); 72-80 ; Quality in Sport; Vol. 13 No. 1 (2023); 72-80 ; 2450-3118

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity

Subjects: obesity; agoniści glukagonopodobnego peptydu-1 (GLP-1); semaglutyd

  • Source: Journal of Education, Health and Sport; Tom 13 Nr 4 (2023); 196-205 ; Journal of Education, Health and Sport; Vol. 13 No. 4 (2023); 196-205 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Subjects: non-alcoholic fatty liver disease (NAFLD); NASH; semaglutide

  • Source: Journal of Education, Health and Sport; Tom 13 Nr 4 (2023); 123-131 ; Journal of Education, Health and Sport; Vol. 13 No. 4 (2023); 123-131 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

Liraglutide as an innovative and multifunctional drug for patients with obesity – the current state of knowledge and future prospects

Subjects: liraglutide; obesity; GLP-1 analogues

  • Source: Journal of Education, Health and Sport; Tom 13 Nr 1 (2023); 153-160 ; Journal of Education, Health and Sport; Vol. 13 No. 1 (2023); 153-160 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity.

Subjects: obesity; weight loss; GLP-1 agonists

  • Source: Journal of Education, Health and Sport; Tom 12 Nr 9 (2022); 55-60 ; Journal of Education, Health and Sport; Vol. 12 No. 9 (2022); 55-60 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

Semaglutide for the treatment of obesity

Subjects: semaglutide; GLP-1 analogue; overweight

  • Source: Journal of Education, Health and Sport; Tom 12 Nr 8 (2022); 1111-1123 ; Journal of Education, Health and Sport; Vol. 12 No. 8 (2022); 1111-1123 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1 analogs in the treatment of obesity

Subjects: glucagon-like peptide-1; obesity; GLP-1 receptor expression

  • Source: Journal of Education, Health and Sport; Tom 12 Nr 8 (2022); 334-342 ; Journal of Education, Health and Sport; Vol. 12 No. 8 (2022); 334-342 ; 2391-8306

Record details

Read More Add to Saved list
×
Academic Journal

The treatment of diabetes with new generation drugs

Subjects: diabetes; GLP-1 analogues; SGLT-2 inhibitors

  • Source: Journal of Education, Health and Sport; Tom 10 Nr 9 (2020); 690-696 ; Journal of Education, Health and Sport; Vol. 10 No. 9 (2020); 690-696 ; 2391-8306

Record details

Read More Add to Saved list
×
  • 1-9 of  9 results for ""glp-1""